Ptosis, diplopia and statins: An association?

European Journal of Neurology

Volumn 15, Issue 10, 2008, Pages

  Elsais, A ^a   Lund, C ^a   Kerty, E ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Drug induced; Myasthenia gravis; Statin

Indexed keywords

ATORVASTATIN; AZATHIOPRINE; EDROPHONIUM CHLORIDE; EZETIMIBE; IMMUNOGLOBULIN; PRAVASTATIN; PYRIDOSTIGMINE;

ADULT; CASE REPORT; DIPLOPIA; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; HEART INFARCTION; HUMAN; HYPERLIPIDEMIA; LETTER; MALE; MYALGIA; PRIORITY JOURNAL; PTOSIS; STRABISMUS SURGERY;

EID: 51349116112     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2008.02234.x     Document Type: Letter

References (6)

1. Argov A, Kaminski HJ, Al-udallal A, Ruff RL. Toxic and iatrogenic myopathies and neuromuscular transmission disorders. In : Karpati G, Hilton-Jones D, Griggs RC, eds. Disorders of Voluntary Muscle. Cambridge : Cambridge University Press, 2001 : 676 688.
2. Purvin V, Kawasaki A, Smith KH, Kesler A. Statin-associated myasthenia gravis: report of 4 cases and review of the literature. Medicine 2006 85 : 82 85.
3. Neuhaus O, Hartung HP. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis. Expert Review of Neurotherapeutics 2007 7 : 547 556.
4. Rudski L, Rabinovitch MA, Danoff D. Systemic immune reactions to HMG-CoA reductase inhibitors. Report of 4 cases and review of the literature. Medicine 1998 77 : 378 383.
5. Kaminski HJ, Li Z, Richmonds C, Ruff RL, Kusner L. Susceptibility of ocular tissues to autoimmune diseases. Annals of the New York Academy of Sciences 2003 998 : 362 374.
6. Florentin M, Liberopoulos EN, Elisaf MS. Ezetimibe-associated adverse effects: what the clinician needs to know. International Journal of Clinical Practice 2008 62 : 88 96.